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Enhancing Blood Glucose Prediction with Meal
Absorption and Physical Exercise Information
Chengyuan Liu, Josep Vehı´, Nick Oliver, Pantelis Georgiou and Pau Herrero
Abstract—Objective: Numerous glucose prediction algorithm
have been proposed to empower type 1 diabetes (T1D) manage-
ment. Most of these algorithms only account for input such as glu-
cose, insulin and carbohydrate, which limits their performance.
Here, we present a novel glucose prediction algorithm which, in
addition to standard inputs, accounts for meal absorption and
physical exercise information to enhance prediction accuracy.
Methods: a compartmental model of glucose-insulin dynamics
combined with a deconvolution technique for state estimation
is employed for glucose prediction. In silico data corresponding
from the 10 adult subjects of UVa-Padova simulator, and clinical
data from 10 adults with T1D were used. Finally, a comparison
against a validated glucose prediction algorithm based on a latent
variable with exogenous input (LVX) model is provided. Results:
For a prediction horizon of 60 minutes, accounting for meal
absorption and physical exercise improved glucose forecasting
accuracy. In particular, root mean square error (mg/dL) went
from 26.68 ± 3.58 to 23.89 ± 3.32, p < 0.001 (in silico data);
and from 37.02 ± 5.14 to 35.96 ± 4.65, p < 0.001 (clinical
data - only meal information). Such improvement in accuracy
was translated into significant improvements on hypoglycaemia
and hyperglycaemia prediction. Finally, the performance of the
proposed algorithm is statistically superior to that of the LVX
algorithm (26.68 ± 3.58 vs. 32.80 ± 4.58, p < 0.001 (in silico
data); 37.02 ± 5.14 vs. 49.17 ± 13.80 p < 0.01 (clinical data).
Conclusion: Taking into account meal absorption and physical
exercise information improves glucose prediction accuracy.
Index Terms—Diabetes, glucose prediction, deconvolution, ar-
tificial pancreas.
I. INTRODUCTION
TYPE 1 diabetes mellitus (T1DM) is an autoimmunecondition characterized by elevated blood glucose levels
due to the lack of endogenous insulin production [1]. People
with T1DM require exogenous insulin delivery to regulate
glucose levels. Current therapies for T1DM management re-
quire measuring capillary glucose levels several times per
day and the administration of insulin by means of multiple
daily injections (MDI) or continuous subcutaneous insulin
infusion (CSII) with pumps. More recently, the appearance
of subcutaneous continuous glucose monitoring (CGM) al-
lows access to virtually continuous glucose concentrations
measurements (e.g. every 5 minutes), glucose rate-of-change,
and allows their retrospective analysis. In addition, real-time
devices include alerts and alarms for concentrations outside
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of specified ranges and or rapid changes in glucose. Clinical
data suggest that CGM can improve overall glucose control,
as measured by glycated haemoglobin [2], and can reduce the
burden of extreme glucose values (hypo- and hyperglycaemia)
[3]. In addition, CGM technology has opened the door to
new technologies for managing glucose levels such as sensor-
augmented insulin pumps with low-glucose insulin suspension
[4] and the artificial pancreas [5]. One important feature of
CGM-based technologies is the ability to forecast glucose
concentrations in order to avoid undesired events, such as
hypoglycaemia and hyperglycaemia, by enabling pre-emptive
action (e.g. insulin dose to address hyperglycaemia).
Several glucose forecasting algorithms have been proposed
by different authors, with a comprehensive and extensive
review being recently published, which provides a taxonomy
of the different types of existing algorithms [6]. In addition,
commercial applications of such technology already exists in
the form of sensor-augmented insulin pumps (e.g. Medtronic
MiniMed 640G with Smart Guard) that has been proven
to reduce nocturnal hypoglycaemia using predictive glucose
alerts and a predictive low-glucose insulin suspension system
[4].
Some glucose prediction algorithms use continuous glucose
monitoring (CGM) data as the unique source of information to
forecast glucose levels while others use additional exogenous
inputs such as meal intake and insulin injections, which are
know to influence blood glucose levels [6]. Taking such infor-
mation into account has been proven to improve forecasting
accuracy [7]. Furthermore, additional information such as meal
absorption and physical exercise information can potentially
further improve accuracy [8], [9].
In this work, we introduce a novel model-based glucose
prediction algorithm which uses deconvolution of the CGM
signal to estimate some model states in order to improve
prediction accuracy. In addition to using CGM data, insulin bo-
luses and carbohydrate intake information, information about
meal absorption and physical exercise is taken into account to
further enhance prediction accuracy. For comparison purposes,
the latent variable with exogenous input (LVX) algorithm
proposed by Zhao et al. has been selected as reference in
glucose forecasting since it has showed superiority when
compared against existing techniques in the literature and its
source code is publicly available [7]. The proposed algorithm
is evaluated for different prediction horizons ranging from 5
to 120 minutes, with special focus on the 60-minute horizon
[6]. Finally, predictive hypoglycaemia and hyperglycaemia
prediction capabilities of the tested algorithms are evaluated.
For testing purposes, the UVa-Padova type 1 diabetes sim-
2ulator (T1DMS) [10] was extended in order to include a
physical exercise model, a richer meal-model library and intra-
day variability. In addition, a two-week clinical dataset from a
cohort of 10 adult subjects with T1DM was employed. Finally,
the performance of the tested algorithms was evaluated by
means of root mean square error (RMSE) and Clarke Error
Grid Analysis (EGA).
II. METHODS
The proposed glucose prediction algorithm is based on
composite minimal model of glucose-insulin regulation in type
1 diabetes [11] that uses deconvolution of the continuous
glucose monitoring (CGM) signal to estimate some of the
model states. In particular, the states of the gastrointestinal
model are estimated using the technique proposed by Herrero
et al. [12], which has been proved to be a simple but effective
way to estimate the glucose rate of appearance from mixed
meals. Finally, meal information (i.e., carbohydrate amount
and absorption type), insulin boluses and physical exercise
are considered as exogenous inputs. Note that compared to the
model used in the T1DM simulator, the employed composite
minimal model is relatively simple and easy to identify,
while providing sufficient complexity to model glucose-insulin
dynamics. The effectiveness of such composite model was
evaluated by Gillis et al. for glucose prediction using a
Kalman filter technique [13] and by Herrero and associates
for detecting faults in insulin pump therapy [11].
A. Composite minimal model
The employed composite model of glucose regulation in
type 1 diabetes is composed of the minimal model of glucose
disappearance proposed by Bergman and colleagues [14], and
the insulin and carbohydrate absorption models proposed by
Hovorka et al.[15].
1) Minimal model of glucose disappearance: The minimal
model of glucose disappearance [14] is described by the
equations
G˙(t) = −(SG +X(t))G(t) + SGGb +
Ra(t)
VW
, (1)
X˙(t) = −p2X(t) + p2SII(t), (2)
where G(t) is the glucose concentration, X(t) is the insulin
action, Ra is the glucose rate of appearance from ingested
meals, I(t) is the plasma insulin concentration, SG is the
fractional glucose effectiveness, SI is the insulin sensitivity,
p2 is the insulin action rate, Gb is the basal glucose, V is the
distribution volume, and W is the subject’s body weight.
2) Insulin absorption model: The plasma insulin concen-
tration is estimated by means of the subcutaneous insulin
absorption model proposed by Hovorka et al. [15], which is
described by the following equations.
S˙1(t) = u1(t)−
S1(t)
tmaxI
, (3)
S˙2(t) =
S1(t)− S2(t)
tmaxI
, (4)
I˙(t) = −keI(t) +
S2(t)
VitmaxI
, (5)
where S1(t) and S2(t) are the subcutaneous short-acting
insulin compartments, I(t) denotes the plasma insulin con-
centration, the input u1(t) represents the subcutaneous insulin
infusion, tmaxI is the time to maximum insulin absorption, Vi
is the distribution volume of insulin and ke is the decay rate.
3) Glucose absorption model: The glucose rate of ap-
pearance (Ra) is calculated according to the gastrointestinal
absorption model by Hovorka et al. [15], which is represented
by the equations
R˙a1(t) = −
Ra1(t)−Agu2(t)
tmaxG
, (6)
R˙a(t) = −
Ra(t)−Ra1(t)
tmaxG
, (7)
where Ra1(t) denotes the glucose appearance in the first
compartment, Ra(t) represents the rate of glucose appearance,
the model input u2(t) denotes the carbohydrate intake amount,
tmaxG is the time to maximum glucose rate of appearance and
Ag is the carbohydrate bioavailability .
4) Physical exercise: Schiavon and coauthors have showed
that physical exercise produces significant changes on insulin
sensitivity [16], [17]. Since the effect of physical exercise
on glucose uptake and insulin sensitivity is not explicitly
modelled within the employed minimal model, its effect is
taken into account by modifying the parameter SI , which
models the ratio between endogenous glucose production
and glucose uptake, during the duration of the exercise. In
particular, insulin sensitivity was modified as follows
SI :=
{
kexS
o
I , during exercise
SoI , during resting
(8)
where SoI is the insulin sensitivity in absence of exercise
and kex is a constant that represents the effect of physical
exercise on insulin sensitivity. Note that the employed model
of physical exercise only accounts for the short-term effect
of anaerobic on glucose levels (i.e. glucose update) and does
not account for the long-term effect on insulin sensitivity. In
this work, a 30-minute exercise at 50% VO2max (see Section
II-D) has been considered, and kex was empirically fixed to
3.
5) Meal absorption: Meal composition has a profound
effect on blood glucose levels [9]. Therefore, taking this infor-
mation into account can potentially enhance glucose forecast-
ing performance. To account for this information in a practical
way from the user’s perspective, meals were classified as fast,
medium and slow absorption. In particular, fast-absorption
meals were considered have more than 60% of the area under
the curve (AUC) of the rate of glucose appearance (Ra) profile
appeared within the first two hours since the meal ingestion;
a slow-absorption meals to have less than 80% of AUC of Ra
profile appeared within four hours, and medium-absorption
meal otherwise. To take meal absorption information into
account within the employed glucose absorption model, the
time-to-maximum absorption rate tmaxG was modified as
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Fig. 1: Ra profiles corresponding to the fast, slow and medium
meals of the employed UVa-Padova simulator for a 60 grams
intake of carbohydrates.
follows
tmaxG :=


tomaxG − tl, fast absorption
tomaxG, medium absorption
tomaxG + td, slow absorption
(9)
where tomaxG is the default time-to-maximum absorption rate
(i.e. medium absorption) for a given subject, tl and td represent
the time shift on the time-to-maximum absorption rate due to
different meal absorption rates. In particular, tl and td were
empirically fixed to 20 minutes.
Fig. 1 shows the average Ra profiles corresponding to the
fast, slow and medium meals of the employed UVa-Padova
simulator for a 60 grams intake of carbohydrates.
B. Glucose prediction algorithm
The proposed glucose prediction algorithm uses a discre-
tised version of the presented composite model (Equations
1-7). For this purpose, a forward Euler’s Configuration with
1-minute step size is used to simulate the model.
Let
x(k) = f(x(k − 1), p, u(k − 1))
be the system equations representing a discre-
tised version of the described composite model,
where k denotes the sampling instant. Let x =[
G X S1 S2 I Ra1 Ra
]
represent the model states;
p =
[
ke tmaxI Vi Ag tmaxG SG p2 W V SI
]
repre-
sent the model parameters; and u =
[
CHO IB EX MA
]
represent the model inputs, where CHO denotes the amount
of ingested carbohydrates, IB denotes the insulin boluses
(units), EX denotes an exercise flag (i.e. true or false) and
MA denotes the meal absorption (i.e. slow, medium, fast).
To improve the forecasting capability of the proposed algo-
rithm, the model states of the gastrointestinal sub-model (Ra
and Ra1) are estimated in real-time (e.g. every 5 minutes) by
doing a deconvolution of the continuous glucose monitoring
signal using the technique proposed by Herrero et al. [12].
Such models estates were selected for being highly dependent
on meal composition. The glucose rate of appearance (Ra) in
the second compartment is estimated as
Rˆa(k) =
[
G˙(k) + (SG +X(k))G¯(k)− SGGb
]
VW, (10)
where G˙ is the derivative of the glucose measurements calcu-
lated as the slope of the linear regression of three consecutive
glucose values, G¯ is the sensor measurement and X is the
insulin action (Equation 2). In order to reduce the influence
of the measurement disturbance, the derivative is bounded by
|G˙| ≤ 1 mg/dL per min. To further reduce the effect of sensor
noise on the Rˆa estimation, a moving average filter is applied,
Rˆa(k) :=
∑i=k
i=k−n Ra(i) + Rˆa(i)
(n+ 1)
, (11)
where n is the length of the moving window (n = 3).
The glucose appearance in the first compartment is then
estimated as
Rˆa1(k) = R˙a(k)tmaxG + Rˆa(k), (12)
where R˙a is the derivative of Rˆa.
Then, the states Ra and Ra1 are calculated as a weighted
average between the simulated values with the model f and
the estimated ones by the deconvolution technique as follows
Ra(k) := QRˆa(k) + (1 −Q)Ra(k), (13)
Ra1(k) := QRˆa1(k) + (1−Q)Ra1(k). (14)
where Q ∈ [0, 1] is a tuning parameters that allows putting
more weight on the model estimation or on the deconvolution
technique. Note that parameter Q allows to decide if more
trust is put on the model estimation (Ra) or on the estimation
using deconvolution (Rˆa).
Similarly, the plasma glucose state is updated as
G(k) := QG¯(k) + (1−Q)G(k). (15)
Finally, the discrete model f is evaluated over the prede-
fined prediction horizon (PH) to obtain the desired forecasted
glucose.
In this works, prediction horizons ranging from 5 to 120
minutes are evaluated (Figure 2). However, special empha-
sis is put on the 60-minute horizon since it is one of the
most employed ones in the literature [6] and is the horizon
currently used by the predictive low-glucose insulin suspend
(SmatGuard) implemented in the Medtronic MiniMed 640G
sensor-augmented insulin pump (Medtronic, Northridge, CA,
US).
C. Model parameter identification
The proposed glucose prediction algorithm is individualised
by identifying some of the model parameters using retro-
spective data. Since identification of all model parameters
is not possible due to identifiability problems, some of the
parameters, which are know to have less inter-subject vari-
ability, were fixed to mean populations values (i.e. SG, V ,
4Vi, ke, p2, Ag) [18], while others were set by using a priori
known information from the subjects, such as body weight
(W ) and basal glucose (Gb). Finally, parameters SI , tmaxI
and tmaxG were identified by minimising the mean absolute
relative difference (MARD) between the predicted glucose
(Gf ) and the corresponding glucose measurements. Matlab
fmincon constrained optimisation routine was employed for
this purpose. Constraints for the identified parameters were
SI ∈ [0.001, 0.005] min
−1 per µU/ml, tmaxI ∈ [50, 140]
min and tmaxG ∈ [50, 140] min. Table I shows the employed
values for the model parameters indicating which ones are a
priori known and which ones are identified.
D. In silico testing
The latest version of the UVa-Padova T1DM simulator
(v3.2) [10] was used to evaluate the proposed glucose fore-
casting algorithm. The 10 available adult subjects were used
for this purpose. The open-loop insulin therapy provided by
the simulator was employed to generate the datasets. A one-
week scenario with a daily pattern of carbohydrate dose
intake of 7am (70g), 13pm (100g) and 7pm (80g) (±20min)
was chosen. The selected CGM and insulin pump models
to perform the simulations were the Dexcom G4 and Deltec
Cozmo.
Intra-day variability was emulated by modifying some of the
parameters of the model described in [19]. In particular, meal
variability was emulated by introducing meal-size variability
(CV = 10%), meal-time variability (STD = 20) and un-
certainty in the carbohydrate estimation (uniform distribution
between −30% and +20%) [20]. Meal absorption rate (kabs)
and carbohydrate bioavailability (f ) were considered to vary
by ±30% and ±10% respectively. To account for variability
in meal composition, the 33 available meals in the simulator
were considered. Note that each cohort had 11 different meals
(i.e. 10 individuals plus an average individual). In addition,
16 mixed meals obtained from clinical data extracted from
scientific publications were included. A mixed-meal model
library was obtained using the technique for estimating the
rate of glucose appearance proposed by Herrero et al. in [12],
[21]. Details about the meal library are provided in Appendix
A. By using the absorption classification criteria introduced
in Section II-A5, of the 49 considered meal, 31 were clas-
sified as fast absorption, 15 as medium absorption and 3 as
slow absorption. Intra-subject variability in insulin absorption
model parameter (kd, ka1, ka2) was assumed ±30% [22],
[23]. Finally, physical exercise was introduced as described
in [17]. In particular, a 30-minute exercise CV = 10% at
50% VO2max was considered at 3pm (±20min).
In order to test the benefit of accounting for meal and exer-
cise information in the glucose predictions, four configurations
of the proposed algorithm were considered. These are:
• Configuration 1: exercise and meal type information
(i.e. slow, medium, fast) are not taken into account.
• Configuration 2: only exercise information is taken
into account.
• Configuration 3: only meal type information is taken
into account.
• Configuration 4: both meal type and exercise informa-
tion are taken into account.
The latent variable model with exogenous input (LVX)
algorithm proposed by Zhao et al. [7] was chosen to compare
its performance against the proposed technique.
Finally, in order to train both the proposed algorithm and
the LVX algorithm, a one-week training dataset, different from
the testing scenario, was employed.
E. Clinical data testing
Although significant intra-day variability was considered in
the selected in silico scenario, it still cannot be compared to a
real-life scenario. In order to test the proposed algorithm with
real clinical data, a one-week clinical dataset from the 10 adult
subjects with T1DM undergoing a clinical trial evaluating the
benefits of an advanced insulin bolus calculator was employed
[24]. Since no reliable information about physical exercise
and meal composition was available for the clinical dataset,
the proposed algorithm was evaluated making the assumption
that breakfast is fast absorption and lunch and dinner are
medium absorption (i.e. Configuration 3). Not that not having
such information in a reliable way might limit the benefits
of the proposed algorithm. Finally, the algorithm without
considering information about meal absorption and exercise
(i.e. Configuration 1) and the LVX algorithm were also
evaluated and compared. Two different one-week datasets were
employed for training and testing purposes.
F. Evaluation metrics
In order to evaluate the forecasting accuracy of the algo-
rithms, the root mean square (RMSE) and the percentage of
values in A-region of the Error Grid Analysis (EGA) were
used. RMSE is calculated as
RMSE =
√∑N
k=1(Gˆ− G¯)
2
N
,
where Gˆ is the forecasted value, G¯ the glucose measurement,
and N is the total number of glucose measurements. EGA
express the clinical significance of the error between the fore-
casted glucose value and the actual measurement. In particular,
the A-region of EGA represent the percentage of the forecasted
glucose values that deviate from the actual measurements
within the range of ±20%, or when both the forecasted and the
actual measurements indicate hypoglycaemia (i.e. |Gˆ− G¯| ≤
20%G¯ or Gˆ ≤ 70mg/dL with G¯ ≤ 70mg/dL). Although
other metrics exist to evaluate the clinical significance of
the committed error, such as continuous glucose error grid
analysis, the EGA is the most widely used one [25].
In addition, the efficiency of predicting hypo- and hyper-
glycaemia prediction are evaluated by the sensitivity (SEN),
specificity (SPC), F1 score, and the Matthews correlation
coefficient (MCC). The sensitivity measures the percentage
of correct predictions of hypoglycaemia (or hyperglycaemia)
events and the specificity measures the percentage of correct
5TABLE I: Values of the parameters used in the forecasting algorithm. ∗ indicates parameters that are identified and ∗∗ parameters
that are known from a priori information from the subjects. The rest of the parameters are fixed to mean population values
obtained from the scientific literature [12], [15].
Parameter SG SI Gb V Vi W tmaxI tmaxG ke p2 Ag Q PH
Value 0.02 ∗ ∗∗ 0.9 1.2 ∗∗ ∗ ∗ 1.5 0.02 0.85 0.7 30
Units min−1 min−1 per µU/ml mg/dl dl/kg2 ml/kg kg min min min−1 min−1 – – min
prediction within the target range (e.g. 70mg/dL < G¯ ≤
180mg/dL) with the formula
SEN =
TP
TP + FN
, SPC =
TN
TN + FP
,
where TP denotes the number of true positives (i.e. cor-
rect prediction of hypo-/hyperglycaemia), FN denotes the
number of false negatives (i.e. missed prediction of hypo-
/hyperglycaemia), TN denotes the number of true negatives
(i.e. correct prediction of glucose within target range), and FP
denotes the number of false positives (i.e. false prediction of
hypo-/hyperglycaemia). Finally, two metrics to evaluate the
quality of the binary classifications were included: the F1-
score and the Mathew’s correlation coefficient (MCC). F1
score is calculated as
F1 =
2TP
2TP + FP + FN
,
and MCC as
MCC=
TP · TN−FP · FN√
(TP+FP )(TP+FN)(TN+FP )(TN+FN)
.
III. RESULTS
A. In silico results
The distribution of the identified model parameters for
the employed in silico cohort is SI = 0.00275 ± 0.0014
min−1 per µU/ml, tmaxI = 114.6±21.6 min and tmaxG =
68.9± 6.8 min.
For the 10 virtual adult subjects, Table II shows: the pre-
diction accuracy expressed as RMSE and the percentage of
pairs (i.e predicted vs. measurement) in region A of the EGA
for different prediction horizons corresponding to the four
configurations and LVX algorithm. Table III shows the sen-
sitivity, specificity, F1 score and the MCC of hypoglycaemia
and hyperglycaemia prediction with a prediction horizon of
60 minutes, corresponding to the four evaluated configura-
tions and the LVX model-based algorithm . Such results are
expressed as mean and standard deviation (Mean ± STD)
and statistical significance with respect to the row below is
indicated with ∗ for p < 0.001, + for p < 0.01, and T for
p < 0.05.
Fig. 2 shows the mean RMSE with regard to the predic-
tion horizons for the four considered configurations and the
LVX algorithm. Fig. 3 shows a two-day period close-up of
the prediction results for subject adult 1 corresponding to
Configuration 1 and the LVX method. Note that the LVX
method tends to overestimate or underestimate glucose values
in the peaks and troughs.
0 20 40 60 80 100 120
0
10
20
30
40
50
60
70
80
90
Configuration 4
Configuration 3
Configuration 2
Configuration 1
LVX
Fig. 2: Mean RMSE, in mg/dL, for the four configurations
and the LVX algorithm against to evaluated prediction hori-
zons corresponding to the 10 virtual adults.
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Fig. 3: Two-day period close-up of the prediction results for
subject adult 1. The simulated continuous glucose measure-
ments are showed in solid blue line, the prediction results
of the LVX method are showed in dotted green line, and
the prediction results of the Configuration 1 are showed
in dashed red line. Vertical pink bars indicate carbohydrate
intakes (grams) and vertical light blue bars indicate insulin
boluses (units).
B. Clinical data results
The distribution of the identified model parameters for
the employed 10-adult cohort are SI = 0.0011 ± 0.00015
6TABLE II: RMSE (mg/dL) and A-region of the EGA (%) expressed in Mean±STD for the four considered configurations
and the LVX algorithm corresponding to different prediction horizon (PH in minutes) and evaluated on the 10-adult virtual
population. The statistical significance with respect to the row below is indicated with ∗ for p < 0.001, + for p < 0.01 and T
for p < 0.05
.
Config-
PH = 30 PH = 60 PH = 90 PH = 120
uration
RMSE A-region RMSE A-region RMSE A-region RMSE A-region
(mg/dL) (%) (mg/dL) (%) (mg/dL) (%) (mg/dL) (%)
4 13.04±1.64∗ 93.43±1.72∗ 23.89±3.32∗ 77.86±5.36∗ 33.11±4.50+ 66.14±5.75+ 39.14±5.60∗ 58.47±5.73+
3 13.79±1.75∗ 92.24±1.84 24.84±3.34∗ 77.14±5.18∗ 33.95±4.54∗ 65.74±5.79∗ 39.81±5.64∗ 58.14±5.66∗
2 13.69±1.66T 92.63±1.69∗ 25.75±3.54+ 74.84±5.66∗ 35.54±4.75∗ 61.82±6.44T 42.21±5.82∗ 53.58±5.98
1 14.40±1.77∗ 91.44±1.85 26.68±3.58∗ 74.32±5.52+ 36.38±4.80∗ 61.56±6.42+ 42.88±5.86∗ 53.39±5.82∗
LVX 16.24±2.12 91.37±1.75 32.80±4.58 68.85±6.74 59.09±17.39 40.83±17.28 87.44±27.57 26.09±16.44
TABLE III: Hypoglycaemia and hyperglycaemia prediction results for the 10 virtual adult subjects considering a 60 minutes
prediction horizon. Results are expressed asMean±STD and statistical significance with respect to the row below is indicated
with ∗ for p < 0.001, + for p < 0.01 and T for p < 0.05.
Config- Hypo SEN Hypo SPC Hypo F1 Hypo MCC Hyper SEN Hyper SPC Hyper F1 Hyper MCC
uration (%) (%) (%) (%) (%) (%) (%) (%)
4 93.30±1.88+ 97.65±0.91+ 87.20±4.01+ 85.91±3.84+ 65.88±9.07T 96.18±2.88 60.42±11.99+ 57.75±9.54+
3 92.54±1.95T 97.58±0.87+ 86.43±4.54 85.07±4.31 64.37±9.90 96.08±2.92T 59.26±12.99+ 56.46±10.69+
2 92.10±2.26+ 97.69±0.96T 86.79±4.03+ 85.40±3.91+ 61.83±10.29T 95.79±3.21 56.99±13.17+ 53.87±10.90+
1 91.61±2.22∗ 97.64±0.93+ 86.30±4.22∗ 84.85±4.08∗ 60.28±11.72∗ 95.68±3.31 55.87±13.93∗ 52.59±11.85∗
LV X 83.39±5.23 93.18±3.19 68.17±11.99 65.68±10.75 44.68±12.47 95.46±1.18 42.18±17.09 38.22±14.82
min−1 per µU/ml, tmaxI = 78.36 ± 16.52 min and
tmaxG = 85.23± 24.86 min.
For the 10 adult subjects, Table IV presents the
RMSE and the A-region (Mean ± STD) corresponding to
Configuration 3, Configuration 1 and LVX method
for the different prediction horizons evaluated on the 10
adult subjects. Table V shows the sensitivity, specificity, F1
score and the MCC of hypoglycaemia and hyperglycaemia
prediction with a prediction horizon of 60 minutes. These
results correspond to Configuration 3, Configuration 1
and the LVX model-based algorithm. Results are expressed as
Mean± STD and statistical significance with respect to the
row below is indicated with ∗ for p < 0.001, + for p < 0.01,
and T for p < 0.05.
Fig. 4 shows the mean RMSE for different prediction hori-
zons corresponding to Configuration 3, Configuration 1
and LVX algorithm. Fig. 5 shows a two-day period close-
up of the prediction results for Configuration 1 and LVX
algorithm corresponding to a selected subject .
IV. DISCUSSION
The obtained results show that accounting for information
about physical exercise can significantly improve the accuracy
of a glucose forecasting algorithm, having the information
about meal composition has a bigger impact on the results.
However, the major improvement is achieved when both
sources of information are taken into account (e.g. RMSE
(mg/dL) from 26.68±3.58 to 23.89±3.32 (in silico data)). The
improvement in accuracy has a significant impact on hypogly-
caemia and hyperglycaemia prediction, having a major impact
on the latter one (F1: from 55.87±13.93% to 60.42±11.99%
and MCC: from 52.59± 11.85% to 57.75± 9.54%).
Note that accounting for meal absorption requires an ad-
ditional input by the user. Hence, in addition to standard
training carbohydrate counting, people with T1D should also
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Fig. 4: Mean RMSE, in mg/dL, corresponding to
Configuration 3, Configuration 1 and LV X algorithm
for different prediction horizons and evaluated on 10 adults
subjects.
receive training to learn how to classify between slow, medium
and faster absorption meals. Also note that physical activity
information can be easily gathered using off-the-shelf activity
monitors (e.g. Fitbit), but could also be manually entered.
The presented results show that the proposed algorithm
outperforms the LVX model-based algorithm proposed by
Zhao et al. [7] (26.68± 3.58 vs. 32.80± 4.58). These results
are consistent in the both evaluated in silico and clinical
scenarios. Note that the difference in performance between the
two algorithms is much more accentuated for longer prediction
horizons. Finally, it is important to remark the significantly
smaller standard deviation of the proposed algorithm performs
when compared to the LVX algorithm, which seems to indicate
7TABLE IV: RMSE (mg/dL) and A-region of EGA (%) expressed (Mean±STD) for Configuration 3, Configuration 1
and the LVX algorithm corresponding to different prediction horizon (PH in minutes) and evaluated on the 10 adult subjects.
The statistical significance with respect to the row below is indicated with ∗ for p < 0.001, + for p < 0.01 and T for p < 0.05
.
Config-
PH = 30 PH = 60 PH = 90 PH = 120
uration
RMSE A-region RMSE A-region RMSE A-region RMSE A-region
(mg/dL) (%) (mg/dL) (%) (mg/dL) (%) (mg/dL) (%)
3 25.06±5.33 83.05±7.51 35.96±4.65∗ 71.57±6.60∗ 41.84±3.32∗ 66.72±4.71∗ 44.73±3.26∗ 65.25±4.27+
1 25.40±5.66∗ 82.75±7.87 37.02±5.14+ 70.82±6.82+ 43.25±3.67∗ 65.91±4.73∗ 46.51±3.70∗ 64.45±4.23∗
LV X 30.00±9.66 81.13±10.67 49.17±13.80 62.55±12.58 64.74±18.21 50.74±12.71 76.94±21.28 43.02±11.78
TABLE V: Hypoglycaemia and hyperglycaemia prediction results for the 10 adult subjects considering a 60 minutes prediction
horizon. Results are expressed as mean and standard deviation (Mean± STD) and statistical significance with respect to the
row below is indicated with ∗ for p < 0.001 and T for p < 0.05.
Config- Hypo SEN Hypo SPC Hypo F1 Hypo MCC Hyper SEN Hyper SPC Hyper F1 Hyper MCC
uration (%) (%) (%) (%) (%) (%) (%) (%)
3 67.24±12.56+ 95.42±3.78 49.99±12.59+ 48.85±12.86+ 86.66±7.21 88.21±3.26T 84.36±9.64 73.92±8.97T
1 66.26±11.96+ 95.26±3.81+ 48.71±12.18∗ 47.57±12.32∗ 86.67±7.31∗ 88.00±3.23 84.28±9.65∗ 73.73±8.98∗
LV X 60.54±14.40 93.79±5.16 40.52±13.90 39.30±13.70 78.17±12.06 87.26±3.76 79.33±11.56 65.64±10.43
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Fig. 5: two-day period close-up of the prediction results for
Configuration 1 and LV X method. The simulated contin-
uous glucose measurements are showed in solid blue line, the
prediction results of the LVX method are showed in dotted
green line, and the prediction results of the Configuration 1
are showed in dashed red line. Vertical pink bars indicate
carbohydrate intakes (grams) and vertical light blue bars
indicate insulin boluses (units).
that our approach generalises better.
V. CONCLUSION AND FUTURE WORK
Accounting for information about meal absorption (slow,
medium, fast) and physical exercise (duration and intensity)
improves the performance of a glucose forecasting algorithm,
having the information about meal composition has a bigger
impact on the results. When compared against an existing
glucose forecasting algorithm (LVX model), the proposed
algorithm, based on a compartmental model of glucose-
insulin dynamics combined with a deconvolution technique
for state estimation, provides superior performance in terms
of prediction accuracy and hypoglycaemia and hyperglycaemia
prediction. Although the obtained results are conclusive, using
longer datasets for training the models could lead to improved
results.
The presented algorithm is currently being clinically eval-
uated as part of the safety system of a mobile-based decision
support system for type 1 diabetes management within the
framework of the European project PEPPER (Patient Em-
powerment through Predictive PERsonalised decision support)
[26]. Current work to further improve the accuracy of the
proposed algorithm include accounting for insulin sensitivity
circadian variations and a physical exercise model to account
for the long term effect of exercise on insulin sensitivity.
APPENDIX A
MIXED-MEAL MODEL LIBRARY
To build the employed mixed-meal model library within
the UVa-Padova T1DM simulator [10], the scientific literature
was reviewed for clinical trials studying the effect of meal
composition on non-diabetic subjects, which included mean
population plasma glucose and plasma insulin concentration
data, meal composition, and body weight. In addition, the
duration of the trial needs to be long enough to allow glucose
and insulin levels at the end of the trial to return to basal
conditions and the sampling rate needs to be high enough
to capture glucose and insulin dynamics. Data from 16 mixed
meals fulfilling the above criteria were found in scientific pub-
lications for healthy subjects. Table VI shows the information
for each of the selected mixed meals, average weight of the
studied subjects and the corresponding bibliographic reference.
To estimate the rate of glucose appearance (Ra) correspond-
ing to the chosen meals, a simple technique for estimating
Ra proposed and validated by Herrero and colleagues was
employed [12]. The employed technique, which is based on the
glucose-insulin minimal model, only requires the identification
of the insulin sensitivity from the minimal model, since it is
based on the hypothesis that the rest of the model parameters
can be considered to vary in relatively small ranges. This
hypothesis originates from the experimental evidence that
inter-subject variability of these parameters is not very large
[27].
8TABLE VI: Mixed meals information and bibliographic references.
Meal # Ingredients Weight (Kg) CHO (g) CHO; Prot.; Fat (% energy) Reference
1 Scrambled eggs, Canadian bacon, Gelatin (Jell-O) 77 77 45; 15; 40 [18]
2 White bread, low-fat cheese, sucrose, oil, butter 82.3 111 55; 15; 30 [28]
3 Fat Milk, white rice, low-fat cheese, fructose, pear, bran-cookies, oil 82.3 112.3 55; 15; 30 [28]
4 Pasta, oil (low fat) 57 75 80; 15.4; 4.6 [29]
5 Pasta, oil (medium fat) 57 75 56; 10.8; 33.2 [29]
6 Pasta, oil (high fat) 57 75 37.4; 7.2; 55.4 [29]
7 Rice, pudding, sugar and cinnamon 65⋆ 50.5 74.6; 14.2; 11.2 [30]
8 Toast, honey, ham, curd cheese, orange juice 65⋆ 50.2 26.2; 16.5; 56.7 [30]
9 Pear barley 59.8 50 79; 15; 5 [31]
10 Instant mashed potato 59.8 50 78; 5.5; 4.5 [31]
11 2 slices of bread, 1 and 1
2
eggs, 1 tea spoon of margarine and orange
juice
65 50 49; 22.3; 28.7 [32]
12 Cereal, coconut, chocolate, fruit and whipping cream 76⋆ 93 18; 16; 66 [33]
13 Oats, coconut, almonds, raisins, honey, sunflower oil, banana, double
cream and milk
61.9 121.1 48.6; 6.9; 48 [34]
14 Same as meal 13 61.9 70.3 28.2; 6.6; 65.2 [34]
15 Same as meal 13 61.9 50 20; 6.1; 73.9 [34]
16 Oat loop cereal, milk, white bread, margarine, strawberry jam, orange
juice
67⋆ 68.8 57; 19; 24 [35]
⋆ Estimated from BMI.
Then, the estimated Ra profiles were fitted to the the
gastrointestinal model of the UVa-Padova T1DM simulator
[36], which equations are described below.
q˙sto1(t) = −k21qsto1(t) +Dδ(t), (16)
q˙sto2(t) = −kempt(t)qsto2(t) + kabsqsto1(t), (17)
q˙gut(t) = −kabs(t)qgut(t) + kempt(t)qsto2(t), (18)
R˙a(t) = −fkabs(t)qgut(t), (19)
where, qsto1 and qsto2 are the amounts of glucose in the
stomach (solid and liquid phase, respectively), k21 is the
rate of grinding in the stomach, δ is the impulse function,
D is the amount of ingested glucose, qgut is the glucose
mass in the intestine, kabs is the rate constant of intestinal
absorption, Ra is the glucose rate of appearance in plasma,
f is the fraction of the intestinal absorption which actually
appears in plasma and kempt is the rate of gastric emptying,
which is represented by a nonlinear function describing a slow
down of glucose emptying rate and later recovery, based on
available physiological knowledge and which depends on the
total amount of glucose in the stomach as follows:
k˙empt(t) = kmin +
kmax − kmin
2
{tanh[α(qsto(t)− bD)]
− tanh[β(qsto(t)− cD)] + 2} , (20)
q˙sto(t) = qsto1(t) + qsto2(t), (21)
α =
5
2D(1− b)
, (22)
β =
5
2Dc
, (23)
where kmin and kmax are the minimal and maximal absorption
rates respectively, b is the percentage of the dose qsto for which
kempt decreases at (kmax − kmin)/2 and c is the percentage
of the dose qsto for which kempt is back to (kmax−kmin)/2.
Table VII show the identified gastrointestinal model pa-
rameters corresponding to the 16 mixed meals presented in
TableVI. Finally, Figure show the curve fitting of 16 estimated
Ra profiles to the selected gastrointestinal model.
To consider the model parameters identification satisfactory,
the following conditions were required to hold, where the op-
erator△ denotes the absolute difference between the reference
and predicted Ra profiles for the corresponding metric:
• Peak value: △Rapeak ≤ 0.3 mg ·min
−1 · kg−1
• Peak time: △Tpeak ≤20 min
• Area-under-the-curve: △AUC ≤ 30 %
• Root mean square error (RMSE): RMSE ≤ 0.5 mg ·
min−1 · kg−1
Furthermore, the coefficient of variation (CV) provided by the
lsqnonlin optimization routine was required to be CV < 50%
and the coefficient of determination (R2) to be above 0.8.
Table VIII show defined metrics for the evaluated Ra profiles.
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